EPIDEMIOLOGY OF SYMPTOMATIC EPILEPSIES IN SMOLENSK REGION
Abstract
Abstract: symptomatic epilepsy remains a difficult problem for the diagnosis and effective treatment. The main epidemiological indicators of symptomatic epilepsies, methods of diagnosis and semiotics attacks, aspects of the therapy probe and combined treatment with primenenie months were studied.
About the Authors
N. N. Maslova
Smolensk State Medical Academy of the Ministry of Health Russian Federation
Russian Federation
Russian Federation
N. V. Yurieva
Smolensk State Medical Academy of the Ministry of Health Russian Federation
Russian Federation
Russian Federation
References
1. Badalyan O.L., Avakyan G.N., Voronina T.A., Nerobkova L.N. The possibility of using a combination of carbamazepine and mexidol in adolescents with partial epilepsy. 2nd Eastern European Conference "Epilepsy and Clinical Neurophysiology": Sat. tr. [Vozmozhnosti ispolzovaniya kombinatsii karbamazepina i meksidola u podrostkov s partsialnoi epilepsiei. 2-ya Vostochno-evropeiskaya konferentsiya «Epilepsiya i klinicheskaya neirofiziologiya»: Sb. tr.]. Crimea, Gurzuf, 2000; 189-190.
2. Gekht A.B., Khauzer V.A., Milchakova L.E., Gusev E.I. Epidemiology of epilepsy in the Russian Federation. Proceedings of the Tenth Congress of neurologists with international participation [Epidemiologiya epilepsii v Rossiiskoi Federatsii. Materialy Kh s"ezda nevrologov s mezhdunarodnym uchastiem]. Nizhny Novgorod. 2012; 277.
3. Glukhova L.Yu., Mukhin K.Yu., Petrukhin A.S., Mironov M.B. Zhurnal nevropatologii i psikhiatrii. 2003; 12: 51-52.
4. Gnezditskii V.V. The inverse problem of EEG and Clinical electroencephalography [Obratnaya zadacha EEG i klinicheskaya elektroentsefalografiya]. Moscow. 2004.
5. Kotov A.S., Rudakova I.G., Belova Yu.A. , Kotov S.V. Symptomatic and presumably symptomatic focal epilepsy with onset in childhood: a view "adult" epileptologa [electronic resource], the mode of access: http://www.epileptologist.ru/ [Simptomaticheskie i predpolozhitelno simptomaticheskie fokalnye epilepsii s debyutom v detskom vozraste: vzglyad «vzroslogo» epileptologa [elektronnyi resurs].
6. Mukhin, K.Yu., Petrukhin A.S. , Mironov M.B. Epilepticheskie sindromy. Diagnostika i terapiya. M. 2008; 223 s.
7. Mukhin K.Yu., Mironov M.B., Gataullina S.Kh., Petrukhin A.S. Rossiiskii meditsinskii zhurnal. 2014; 21: 14-19.
8. Yureva N.V. Use of the drug in patients with meksidol posttraumatic epilepsy. Bulletin of Experimental Biology and Medicine. Attachment 1 [Primenenie preparata meksidol u patsientov s posttravmaticheskoi epilepsiei. Byulleten eksperimentalnoi biologii i meditsiny. Prilozhenie 1]. 2012; 79-86.
9. Boer H.M. The Global Campaign Against Epilepsy as a Model for Raising Awareness. Epilepsia. 2003; 44 (8): 24.
10. Bootsma H.P. et al. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison. Seizure. 2008; 17: 1: 19-26.
11. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies, Patrick Kwan, Alexis Arzimanoglou, Anne T. Berg, Martin J. Brodie, W. Allen Hauser, Gary Mathern, Solomon L. Moshe, Emilio Perucca, Samuel Wiebe, and Jacqueline French. Epilepsia. 2010; 51 (6): 1069-1077.
12. Rambeck B. Antiepileptic drug interactions in polytherapy. Epileptologia. 1998; 6 (2): 43-53.
13. Wolf P. Global Campaign against Epilepsy. Regional declarations and white papers. Epilepsia. 2002; 43 (6): 37-43.
For citation:
Maslova N.N., Yurieva N.V. EPIDEMIOLOGY OF SYMPTOMATIC EPILEPSIES IN SMOLENSK REGION. Epilepsy and paroxysmal conditions. 2014;6(4):72-76. (In Russ.)
Views: 279
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
